CV risk series

This short-track looks at the particular and urgent challenges of identifying and managing patients who are at high or very-high risk of cardiovascular disease (CVD). Identification of these individuals give the opportunity to address and modify the risk before an event occurs.

The first talk covers evaluation of risk, and identification of patients whose risk of CVD is high.

The second talk covers the therapeutic options that can be considered for these patients to reduce their lipid levels to those recommended by current guidelines.

This activity was originally produced as a webinar series for the Lipid Clinic Network.

Language

Presentations are given in English.

Details

Date of preparation: April 27, 2026
Last revised: April 27, 2026
Expiry date: April 27, 2028

By the end of this course, participants will be able to:

• Recognise the clinical characteristics and risk factors that define patients at high and very-high risk of cardiovascular disease in the primary prevention setting.
• Apply contemporary cardiovascular risk estimation strategies and tools to identify individuals who require early and intensive preventive intervention.
• Interpret lipid parameters and additional risk modifiers to improve risk stratification and support personalised treatment planning.
• Identify patients who warrant aggressive lipid-lowering management according to current ESC/EAS guideline recommendations, including those with severe hypercholesterolaemia, diabetes, familial hypercholesterolaemia, chronic kidney disease, or multiple risk factors.
• Describe current evidence-based lipid-lowering treatment options available for high- and very-high-risk patients, including statins, combination therapy, and newer therapeutic agents where appropriate.
• Select appropriate LDL-C targets and therapeutic intensification strategies based on the individual patient’s cardiovascular risk category and residual lipid burden.
• Integrate early detection and optimal lipid management into routine clinical practice in order to reduce the likelihood of first cardiovascular events and improve long-term patient outcomes.

This series is primarily suited to physicians in internal medicine, cardiology, diabetology, endocrinology and in general practice. Outside this group, this educational programme is highly relevant to nurses working in lipid clinics, in cardiovascular prevention, in diabetes and in many other clinics taking care of patients with cardiovascular or metabolic diseases.

The module is especially suitable for:

• specialist nurses and allied healthcare professionals participating in cardiovascular prevention or lipid clinics
• physicians specialising in cardiology
• clinical lipidologists
• specialists in internal medicine
• endocrinologists/diabetologists
• healthcare professionals working in preventive cardiovascular medicine
• general practitioners/family physicians